Bush's stem cell ban to end?

The rumors around Washington, DC say that President Barack Obama could overturn George W. Bush's 2001 federal funding ban on embryonic stem cell research using lines that were derived after August 9 of that year as soon as next week. linkurl:Rick Weiss,;http://www.americanprogress.org/experts/WeissRick.html senior fellow at liberal think tank the Center for American Progress, wrote in an email to __The Scientist__ that, while he has no inside information, there is "a lot of buzz in the advocacy

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The rumors around Washington, DC say that President Barack Obama could overturn George W. Bush's 2001 federal funding ban on embryonic stem cell research using lines that were derived after August 9 of that year as soon as next week. linkurl:Rick Weiss,;http://www.americanprogress.org/experts/WeissRick.html senior fellow at liberal think tank the Center for American Progress, wrote in an email to __The Scientist__ that, while he has no inside information, there is "a lot of buzz in the advocacy community" regarding a lifting of the ban. Weiss continued that the specifics of Obama's imminent announcement are unclear, but that "scientists are going to be happy." linkurl:__Scientific American__;http://www.sciam.com/blog/60-second-science/post.cfm?id=do-parents-of-embryonic-stem-cell-l-2009-01-28 quoted Harold Varmus, a key science adviser to Obama speaking at a meeting of the New York Stem Cell Foundation this week, saying that there is "reason to believe that there will be some executive order in the near future to reverse the Bush doctrine." Obama may detail a new policy with regard to government funding for embryonic stem cell research or he may simply reverse the Bush ban and leave the policy crafting up to officials at the National Institutes of Health or other agencies.
**__Related stories:__***linkurl:FDA OKs stem cell trial;http://www.the-scientist.com/blog/display/55353/
[23rd January 2009]*linkurl:Stem cell supporters upset by Bush veto;http://www.the-scientist.com/news/display/23995/
[20th July 2006]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies